|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 224.47 USD | -0.21% |
|
-0.24% | -1.79% |
| 06-10 | Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon | RE |
| 06-09 | AbbVie Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 10:40 AM |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 227.23 | 236.19 | 236.28 |
| Spread/Res. | -1.25% | -4.99% | -5.03% |
| Spread/Supp. | +5.39% | +13.69% | +18.57% |
| Support | 212.93 | 197.38 | 189.26 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ABBV Stock
- Charts AbbVie Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition